Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
about
ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.Mouse models of thyroid cancer: A 2015 update.Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer.SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse modelMetformin blocks progression of obesity-activated thyroid cancer in a mouse model.Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.Modeling anaplastic thyroid carcinoma in the mouse.Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.Epigenetic Modifications: Novel Therapeutic Approach for Thyroid CancercMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors.Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer.Metabolic Reprogramming in Thyroid Carcinoma.Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK FusionSynergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
P2860
Q33687080-957F21D5-4F72-40E5-8DA1-F6B5DD40C607Q34704914-A35EB675-D13A-4712-B57C-C8075EEE10F7Q35766367-CAF96FBC-5BC8-43B1-9695-F70388484F27Q36351206-C8E00B9F-0046-4A74-A0F3-A7F539D73BADQ36405539-6B4C73B6-C974-4209-B947-421DAAFE808CQ37061023-6F4EECEC-BE3D-458B-AAB2-EA5755BB3A50Q37123127-D53D2C76-CB2A-4ECA-A3D0-A9D9E5AD6E7CQ37376404-1424070B-C64D-44D3-BD44-6EF50B42A8A7Q37743533-1B69A5D3-6C57-4A9A-A19A-3505BA507BCFQ38270915-B65F494F-14F5-4E67-9A6F-F24408D11942Q41418283-6AE1211E-2623-4576-90B0-242188FDBC40Q42101746-2BAF84F9-5EA7-4E1E-AAEC-6BB64FFDDB46Q42281151-483154CF-7C68-4FFE-858F-2A80939A4E0CQ42694831-88CE622D-80AC-4CD3-A52F-660CA78C38DFQ47124483-694911F3-59C4-443E-944A-A6FB6E4052F1Q47552152-A4118926-BA64-4884-AF89-0D1D17F5C8B1Q51075677-7143588F-EC2F-4E50-A5AD-F43FDB2010B8Q53697345-E3F0C189-C12C-4DE8-94B8-5D84EAD1B5D6Q58701147-BB1B1973-9055-4C1A-B458-31AB0417C0C3Q59136532-6E8DEB9D-1E79-49DB-A79C-84022D752AB3
P2860
Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@ast
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@en
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@nl
type
label
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@ast
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@en
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@nl
prefLabel
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@ast
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@en
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@nl
P2093
P2860
P1433
P1476
Synergistic signaling of KRAS ...... cer through MYC up-regulation.
@en
P2093
Jeong Won Park
Mark C Willingham
Sheue-Yann Cheng
Xuguang Zhu
P2860
P304
P356
10.1016/J.NEO.2014.08.003
P577
2014-09-01T00:00:00Z